Correlation Between Replimune and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Replimune and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Replimune and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Monte Rosa.
Diversification Opportunities for Replimune and Monte Rosa
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Replimune and Monte is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Replimune i.e., Replimune and Monte Rosa go up and down completely randomly.
Pair Corralation between Replimune and Monte Rosa
Given the investment horizon of 90 days Replimune Group is expected to generate 1.76 times more return on investment than Monte Rosa. However, Replimune is 1.76 times more volatile than Monte Rosa Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 1,205 in Replimune Group on August 29, 2024 and sell it today you would earn a total of 233.00 from holding Replimune Group or generate 19.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Replimune Group |
| Monte Rosa Therapeutics |
Replimune and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Monte Rosa
The main advantage of trading using opposite Replimune and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Replimune vs. Eliem Therapeutics | Replimune vs. Scpharmaceuticals | Replimune vs. Milestone Pharmaceuticals | Replimune vs. Seres Therapeutics |
| Monte Rosa vs. Eliem Therapeutics | Monte Rosa vs. Scpharmaceuticals | Monte Rosa vs. Milestone Pharmaceuticals | Monte Rosa vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |